Fertility News and Research

RSS

Chemotherapy, radiotherapy have no negative effect on unborn babies

Children who are exposed to chemotherapy or radiotherapy while in the womb suffer no negative impacts on mental or cardiac development, international studies presented at the ESMO 2014 Congress in Madrid have shown.

29 Sep 2014

EMD Serono declares winners of first Grant for Oncology Innovation

EMD Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, today announced the winners of the first Grant for Oncology Innovation (GOI), who will receive grants totaling $1.3 million.

27 Sep 2014

New NIH program awards $2.5 million to spur innovation in mobile health

A new NIH program is awarding nearly $2.5 million to spur innovation in mobile communication technologies and software applications used in biomedical research in low- and middle-income countries (LMICs).

25 Sep 2014

Unisense FertiliTech's EmbryoViewer software gets FDA approval for IVF practices

World leading time-lapse technology provider within the field of IVF, Unisense FertiliTech A/S, has received FDA 510(k) clearance for its "Compare & Select" feature in the EmbryoViewer software - an accessory to the EmbryoScope time-lapse incubator - which assists IVF professionals in selecting embryos for transfer when treating infertile couples or individuals wishing to become a parent.

24 Sep 2014

Study addresses challenge of developing effective strategies to prevent gender-based violence

Gender-based violence affects the physical and mental health of girls and boys, men and women worldwide. A recent study by researchers from the Institute for Reproductive Health at Georgetown University addresses the challenge of developing effective strategies to change inequitable and harmful social norms that result in gender-based violence.

24 Sep 2014

High impact health interventions reduce maternal and child mortality in poor countries

New studies have uncovered the specific interventions and advances that have led to the success with these at-risk populations in the poorest countries.

17 Sep 2014

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Eli Lilly and Company today announced that the RAISE trial, a Phase III study of ramucirumab (CYRAMZA) in combination with chemotherapy in patients with metastatic colorectal cancer (mCRC), met its primary endpoint of overall survival.

15 Sep 2014

Researchers hope to find new ways to combat age-related diseases

Through the study of the roundworm, Caenorhabditis elegans, the team led by Hugo Aguilaniu has discovered a hormone that enhances longevity and reduces fertility, thus reproducing the effects of an extreme diet.

11 Sep 2014

Extraordinary Conceptions hosts free upcoming educational reception in Europe

Extraordinary Conceptions, a leading international egg donor and surrogacy agency based in San Diego County, will be hosting its free upcoming educational reception in Europe.

10 Sep 2014

Canada funds 22 inventive ideas for improving health in low-resource countries

Grand Challenges Canada, funded by the Government of Canada, today announced $2.4 million in seed funds shared between 22 projects from Canada and nine developing nations, to pursue inventive new ideas for improving health in low-resource countries.

8 Sep 2014

Around 9.6% of women diagnosed with dry eye disease, treated with artificial tear eye drops

The symptoms of dry eye disease include the sensation of grit in the eye, frequently accompanied by itching, burning and visual disturbance. The causes are poorly understood.

3 Sep 2014

Research reveals that unplanned births out-of-hospital linked with higher infant mortality

New research reveals that unplanned births out-of-hospital in Norway are associated with higher infant mortality.

3 Sep 2014

Facial masculinity negatively associated with semen quality

Contrary to what one might expect, facial masculinity was negatively associated with semen quality in a recent Journal of Evolutionary Biology study.

3 Sep 2014

Standard Days Method: A highly effective fertility awareness-based family planning method

There is no guarantee that a successful pilot program introducing a health innovation can be expanded successfully to the national, regional, state or even metropolitan level because scaling up is typically complex and difficult.

20 Aug 2014

Longitude and NovaQuest acquire California Cryobank

California Cryobank, a global leader in reproductive tissue donor services and storage and stem cell banking, announced today that it has been acquired by equity investors Longitude Venture Partners II, L.P. and NovaQuest Pharma Opportunities Fund III, L.P..

20 Aug 2014

Researchers validate criteria that predicts early menopause in young cancer survivors

Girls with cancer who are most likely to become infertile after treatment can be identified using guidelines developed almost 20 years ago, new research shows.

19 Aug 2014

Researchers identify microRNAs that differentiate male and female fruit flies

Men and women differ in plenty of obvious ways, and scientists have long known that genetic differences buried deep within our DNA underlie these distinctions. In the past, most research has focused on understanding how the genes that encode proteins act as sex determinants.

19 Aug 2014

Natural killer cells can be used to combat acute lymphoblastic leukemia

Researchers at Children's Hospital Los Angeles have shown that a select team of immune-system cells from patients with leukemia can be multiplied in the lab, creating an army of natural killer cells that can be used to destroy the cancer cells.

19 Aug 2014

Vitamin D deficiency affects fertility in women undergoing IVF

Women with a vitamin D deficiency were nearly half as likely to conceive through in vitro fertilization (IVF) as women who had sufficient levels of the vitamin, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

17 Aug 2014

Testicular cancer incidence: an interview with Dr Rebecca Johnson, Medical Director, Adolescent and Young Adult Oncology Program Seattle Children's Hospital

We observed that, over the past two decades, there has been an increase in the incidence of testicular cancer in Hispanic American adolescents and young adults (AYAs) between 15 and 39 years of age.

15 Aug 2014

Fertility News and Research

Chemotherapy, radiotherapy have no negative effect on unborn babies

EMD Serono declares winners of first Grant for Oncology Innovation

New NIH program awards $2.5 million to spur innovation in mobile health

Unisense FertiliTech's EmbryoViewer software gets FDA approval for IVF practices

Study addresses challenge of developing effective strategies to prevent gender-based violence

High impact health interventions reduce maternal and child mortality in poor countries

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Researchers hope to find new ways to combat age-related diseases

Extraordinary Conceptions hosts free upcoming educational reception in Europe

Canada funds 22 inventive ideas for improving health in low-resource countries

Around 9.6% of women diagnosed with dry eye disease, treated with artificial tear eye drops

Research reveals that unplanned births out-of-hospital linked with higher infant mortality

Facial masculinity negatively associated with semen quality

Standard Days Method: A highly effective fertility awareness-based family planning method

Longitude and NovaQuest acquire California Cryobank

Researchers validate criteria that predicts early menopause in young cancer survivors

Researchers identify microRNAs that differentiate male and female fruit flies

Natural killer cells can be used to combat acute lymphoblastic leukemia

Vitamin D deficiency affects fertility in women undergoing IVF

Testicular cancer incidence: an interview with Dr Rebecca Johnson, Medical Director, Adolescent and Young Adult Oncology Program Seattle Children's Hospital

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News